Hourglass Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
23,130
+2,310
| +11% | +$159K | 0.39% | 68 |
|
|
2025
Q1 | $1.45M | Buy |
20,820
+1,870
| +10% | +$130K | 0.38% | 71 |
|
|
2024
Q4 | $1.63M | Buy |
18,950
+3,330
| +21% | +$286K | 0.45% | 65 |
|
|
2024
Q3 | $1.86M | Buy |
15,620
+140
| +0.9% | +$16.7K | 0.52% | 56 |
|
|
2024
Q2 | $2.21M | Sell |
15,480
-360
| -2% | -$51.4K | 0.66% | 52 |
|
|
2024
Q1 | $2.03M | Buy |
15,840
+700
| +5% | +$89.9K | 0.61% | 52 |
|
|
2023
Q4 | $1.57M | Buy |
15,140
+1,600
| +12% | +$166K | 0.5% | 56 |
|
|
2023
Q3 | $1.23M | Sell |
13,540
-300
| -2% | -$27.3K | 0.43% | 62 |
|
|
2023
Q2 | $1.12M | Buy |
+13,840
| New | +$1.12M | 0.39% | 65 |
|